Background
Dr. Carla Kinslow holds a doctorate in Biomedical Sciences, Cell Biology/Molecular Toxicology with over 35 years of biomedical, regulatory, and environmental experience.
She has expertise in inhalation and oral toxicology; derivation of regulatory screening values for oral and inhalation exposure, toxicogenomics; toxicological risk assessment and communication of such risk to diverse stakeholders; human health impacts analysis from emission events; air, soil, and water monitoring data; modeling data related to ambient air and drinking water quality; water contamination from oil and gas operations; and stakeholder communication.
She specializes in risk-based evaluation of air, soil, and groundwater toxicology under the USEPA, as well as state and federal guidelines. She has served as manager for various regulatory projects where she helped design and implement air monitoring networks, groundwater monitoring projects, and remediation scopes, with subsequent assessment and communication of such human health impacts based on collected data. She has extensive experience in the evaluation of drug and alcohol impairment and “DRAM” shop cases.
Dr. Kinslow also has extensive experience in the evaluation of pesticide/herbicide overspray cases as well as health risks based on genetic predisposition to disease from environmental, occupational, and pharmaceutical exposures. Notably, Dr. Kinslow is also an environmental microbiologist and regularly conducts indoor air quality mold investigations and beer contamination evaluations.
Education and Certifications
- Biomedical Sciences, Cell Biology/Molecular Toxicology, Ph.D.: Biomedical Sciences, Cell Biology/Molecular Toxicology, Ph.D.: University of Texas Medical Branch (2008)
- Molecular Phycology/Marine Ecology, M.S.: Michigan Technological University (1997)
- Biology, B.A.: Indiana University Southeast (1992)
- Society of Toxicology: Full Member
- American Society of Microbiology: Premium Member
- Society of Toxicology of Canada: Regular Member
- University of Texas Medical Branch Alumni Committee: Member
Publications
- “Beyond Science and Decisions: From Problem Formulation to Dose-Response Report from Workshop IV”, Toxicology Excellence for Risk Assessment (TERA), published 2022.
- “Regulatory regions responsive to oxidative stress in the promoter of the human DNA glycosylase gene NEIL2,” Mutagenesis, 2010, Mar; 25(2):171-7.
- “Genetic determinant of NEIL2 transcription,”D. Dissertation.
- “Single nucleotidepolymorphisms 5’ upstream the coding region of the NEIL2 gene influence gene transcription levels and alter levels of genetic damage,” Genes Chromosomes Cancer, 2008 Nov;47(11):923-32.
- “The L84F polymorphism in the O6-Methylguanine-DNA-Methyltransferase (MGMT) gene is associated with increased hypoxanthine phosphoribosyltransferase (HPRT) mutant frequency in lymphocytes of tobacco smokers,” Genomics, 2007 Sep;17(9):743-53.
- “The L84F and the I143V polymorphisms in the O6-methylguanine-DNA-methyltransferase (MGMT) gene increase human sensitivity to the genotoxic effects of the tobacco-specific nitrosamine carcinogen NNK,” Pharmacogenet Genomics, 2005 Aug. 15(8):571-8.
- “Molecular Biology of the marine diatom Achnanthesis longipes,” Master’s thesis, 1997.